Pharmacology

What is the recommended management of grade 4 neutropenia/thrombocytopenia in AML patients being treated with a venetoclax ? Continue with therapy and consider a bone marrow biopsy along with supportive care if patients have not achieved remission-Can interrupt venetoclax if they are in a remission.

en_USEnglish